Overview

Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
0
Participant gender:
All
Summary
The General Objective of this study is to investigate the cost and efficacy of treating patients undergoing colorectal surgical resections with an opioid limited pain control regimen as part of an Enhanced Recovery After Surgery (ERAS) Protocol. This group will be compared to a traditional opioid based pain control regimen.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
OSF Healthcare System
University of Illinois College of Medicine at Peoria
Treatments:
Acetaminophen
Acetaminophen, hydrocodone drug combination
Bupivacaine
Fentanyl
Gabapentin
Hydrocodone
Hydromorphone
Ketamine
Ketorolac
Ketorolac Tromethamine
Lidocaine
Methadone
Morphine
Narcotics
Orphenadrine
Oxycodone
Tramadol
Criteria
Inclusion Criteria:

- Males or females above the age of 18

- Patients undergoing laparoscopic or robotic colorectal resections

Exclusion Criteria:

- History of constipation

- Pre-existing use of narcotics or opioids

- Pre-existing renal or hepatic failure

- Mental illness, mental retardation, or inability to participate in informed consent
due to mental status

- Pre-existing dementia

- Allergy to any protocol medication

- Emergency operation

- Subjects who are incarcerated or wards of the state

- Minors

- Subjects with inflammatory bowel disease, active colitis, or pre-existing
intra-abdominal inflammation. Diverticulitis without active infection/inflammation
will not be excluded.